| Poradosu Enrique |
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2024-11-19 |
$4.99 |
0.0% |
2,000
|
$9,980 |
| Poradosu Enrique |
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2024-05-10 |
$6.29 |
-2.1% |
500
|
$3,145 |
| Poradosu Enrique |
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2023-03-27 |
$11.55 |
-46.7% |
500
|
$5,775 |
| Poradosu Enrique |
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2022-05-12 |
$15.33 |
-59.8% |
670
|
$10,273 |
| Poradosu Enrique |
Chief Science |
Nuvectis Pharma, Inc. (NVCT)
|
2022-02-07 |
$3.44 |
79.0% |
4,600
|
$15,834 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
8.0% |
$3,596 |
$45,007 |